World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
20852
World Ranking
2984
National Ranking
112

Erik Lubberts publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Erik Lubberts sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 196 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Erik Lubberts D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Erik Lubberts sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Erik Lubberts is affiliated with Erasmus University Rotterdam in the Netherlands and has an extensive research portfolio in Medicine and Immunology and Microbiology. Their work primarily focuses on immunology-related fields with significant contributions to Rheumatology, Oncology, Dermatology, and Molecular Biology.

The main research topics addressed in their publications include:

  • Psoriasis: Treatment and Pathogenesis
  • Immunotherapy and Immune Responses
  • Systemic Lupus Erythematosus Research
  • T-cell and B-cell Immunology
  • Immune Response and Inflammation
  • Rheumatoid Arthritis Research and Therapies
  • Dermatology and Skin Diseases

Lubberts has published research in several scholarly journals, with frequent contributions to the following publication venues:

  • European Journal of Immunology
  • Annals of the Rheumatic Diseases
  • Frontiers in Immunology
  • Arthritis & Rheumatology
  • RMD Open

Notable recent papers include:

  • "Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis" (2021), published in Arthritis & Rheumatology
  • "How to Prepare Spectral Flow Cytometry Datasets for High Dimensional Data Analysis: A Practical Workflow" (2021), published in Frontiers in Immunology
  • "Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation" (2021), published in Frontiers in Immunology
  • "Single-Cell RNA Sequencing Reveals Heterogeneity and Functional Diversity of Lymphatic Endothelial Cells" (2021), published in International Journal of Molecular Sciences
  • "Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases" (2022), published in European Journal of Medicinal Chemistry

Frequent co-authors collaborating with Lubberts include:

  • Nadine Davelaar
  • Sophie Brouard
  • Dirk H. Busch
  • Andrea Cossarizza
  • Günnur Deniz

Best Publications

  • Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

    Leslie van der Fits;Sabine Mourits;Jane S. A. Voerman;Marius Kant

  • Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

    D M van der Heijde;M A van 't Hof;P L van Riel;L A Theunisse

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

    Erik Lubberts;Marije I. Koenders;Birgitte Oppers-Walgreen;Liduine van den Bersselaar

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • IL-1-Independent Role of IL-17 in Synovial Inflammation and Joint Destruction During Collagen-Induced Arthritis

    Erik Lubberts;Leo A. B. Joosten;Birgitte Oppers;Liduine van den Bersselaar

  • The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

    Erik Lubberts;Marije I Koenders;Wim B van den Berg

  • The IL-23-IL-17 axis in inflammatory arthritis

    Erik Lubberts

  • IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.

    Erik Lubberts;Liduine van den Bersselaar;Birgitte Oppers-Walgreen;Paul Schwarzenberger

  • Vitamin D in autoimmunity: Molecular mechanisms and therapeutic potential

    Wendy Dankers;Edgar M. Colin;Jan Piet van Hamburg;Erik Lubberts

  • IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis.

    Martine Chabaud;Erik Lubberts;Leo Joosten;Wim van den Berg

  • Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production.

    J. P. van Hamburg;P. S. Asmawidjaja;N. Davelaar;A. M. C. Mus

  • Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

    L. A. B. Joosten;E. Lubberts;P. Durez;M. M. A. Helsen

  • IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

    Erik Lubberts

  • IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

    Erik Lubberts;Leo A.B. Joosten;Martine Chabaud;Liduine van den Bersselaar

  • Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

    Marije I. Koenders;Erik Lubberts;Birgitte Oppers-Walgreen;Liduine van den Bersselaar

  • 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis

    E. M. Colin;P. S. Asmawidjaja;J. P. van Hamburg;A. M. C. Mus

  • Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.

    Christine Plater-Zyberk;Leo A.B. Joosten;Monique M.A. Helsen;Pascale Sattonnet-Roche

  • A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.

    Ralph Stadhouders;Erik Lubberts;Rudi W. Hendriks

  • Toll-Like Receptor 2 Pathway Drives Streptococcal Cell Wall-Induced Joint Inflammation: Critical Role of Myeloid Differentiation Factor 88

    Leo A. B. Joosten;Marije I. Koenders;Ruben L. Smeets;Marleen Heuvelmans-Jacobs

Frequent Co-Authors

Wim B. van den Berg
Wim B. van den Berg Radboud University
Leo A. B. Joosten
Leo A. B. Joosten Radboud University
Marije I. Koenders
Marije I. Koenders Radboud University
Rudi W. Hendriks
Rudi W. Hendriks Erasmus University Rotterdam
Jay K. Kolls
Jay K. Kolls Tulane University
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
Mohamed Oukka
Mohamed Oukka University of Washington
Louis Boon
Louis Boon University of Amsterdam
Dominique Baeten
Dominique Baeten University of Amsterdam
Carl D. Richards
Carl D. Richards McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare pathways can broaden career opportunities. Many professionals combine immunology expertise with advanced nursing roles, such as becoming a Psychiatric Nurse Practitioner. It's important to consider affordable options, and there are excellent cheap psych np programs available online that balance quality and cost.

Salary transparency plays a crucial role when choosing a career path. For example, those pursuing a Doctor of Nursing Practice (DNP) degree can explore detailed information on dnp salary transparency to make informed decisions based on potential earnings by state.

Transitioning between specialties is common in healthcare. If you’re a Family Nurse Practitioner, programs such as the fnp to acute care np bridge program offer a structured way to expand your skills and enter acute care settings.

For those seeking faster routes, many online options allow accelerated training without compromising quality. The accelerated fnp program is a great example, providing a quicker pathway to becoming a Family Nurse Practitioner while integrating immunology knowledge.

Best Scientists Citing Erik Lubberts

Trending Scientists

Recently Published Articles